Company Corbus Pharmaceuticals Holdings Inc OTC Bulletin Board
Equities
US21833P1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
06-03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
06-03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 30/06/13 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 10/04/14 |
Chief Tech/Sci/R&D Officer | 50 | 02-27 | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 31/12/13 |
Avery Catlin
BRD | Director/Board Member | 75 | 31/07/14 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 30/06/13 |
John Jenkins
BRD | Director/Board Member | 66 | 04/06/18 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 07/04/19 |
Yong Ben
BRD | Director/Board Member | 50 | 28/02/23 |
Peter Salzmann
BRD | Director/Board Member | 56 | 05/03/20 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 19/09/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,686,693 | 10,594,451 ( 99.14 %) | 0 | 99.14 % |
Company contact information
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.46% | 22.78B | |
-11.09% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CRBP Stock
- Stock
- Company Corbus Pharmaceuticals Holdings Inc